The weekly litigation news digest is live. Subscribe now

IP Verse

Jazz Pharmaceuticals Ireland competitive analysis

Loading summary...

Latest patents of Jazz Pharmaceuticals Ireland opposed by its competitors

Explore Jazz Pharmaceuticals Ireland's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3509582
Dec 20, 2023Solvate Form Of (R)-2-Amino-3-Phenylpropyl Carbamate1
EP3509581
Nov 9, 2022Formulations Of (R1
EP2968208
Jul 20, 2022Treatment Of Cataplexy1
EP3335708
Dec 11, 2019Administration Of Gamma Hydroxybutyrate With Monocarboxylate Transporters4
EP2961399
Nov 15, 2017Administration Of Gamma Hydroxybutyrate With Monocarboxylate Transporters3

Latest PTAB cases involving Jazz Pharmaceuticals Ireland

Discover the latest PTAB cases involving Jazz Pharmaceuticals Ireland, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 19, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Jazz Pharmaceuticals Ireland

IPR2016-00738Mar 10, 2016RANBAXYJAZZ PHARMACEUTICALS IRELANDInstitution Denied

Peer Comparison New

IP litigation analysis comparing Jazz Pharmaceuticals Ireland with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
JAZZ PHARMACEUTICALS IRELAND - 10 - 1
HEXAL573 - -
HOFFMANN EITLE148 - - -
SANDOZ1191619 -